Skip to main content
SinoMab BioScience Limited logo

SinoMab BioScience Limited — Investor Relations & Filings

Ticker · 3681 ISIN · HK0000544194 LEI · 9845009B6CEEC4694006 HKEX Manufacturing
Open in API
Filings indexed 319 across all filing types
Latest filing 2019-10-25 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 3681

About SinoMab BioScience Limited

http://www.sinomab.com

SinoMab BioScience Limited is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of therapeutic antibodies. The company focuses on developing novel, highly efficacious drugs, including "first-in-class" and "best-in-class" candidates, primarily for the treatment of immunological and life-threatening diseases, such as rheumatoid arthritis. SinoMab maintains full-spectrum drug development capabilities, covering antibody re-engineering, bioprocessing, and manufacturing, aimed at addressing significant unmet medical needs globally.

Recent filings

Filing Released Lang Actions
PHIP (1st submission)
Capital/Financing Update Classification · 95% confidence The document is a PHIP (Post-Hearing Information Prospectus) for SinoMab BioScience Limited, as indicated by the header and the list of sections typical of an IPO prospectus (e.g., 'Global Offering', 'Underwriting', 'Accountants' Report'). Since the provided categories do not include a specific 'Prospectus' or 'IPO' code, and it is a regulatory filing related to a public offering, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback.
2019-10-25 English
PHIP (1st submission)
Regulatory Filings
2019-10-25 English
Application Proof (1st submission)
Regulatory Filings
2019-07-08 English
Application Proof (1st submission)
Capital/Financing Update Classification · 95% confidence The document is an 'Application Proof' for a prospectus, which is a foundational document for a company's initial public offering (IPO) or global offering. It contains sections typical of a prospectus, such as 'Risk Factors', 'Industry Overview', 'Financial Information', and 'Structure of the Global Offering'. Since the provided categories do not include 'Prospectus' or 'IPO Filing', and it is a regulatory document related to capital raising, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback.
2019-07-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.